171 related articles for article (PubMed ID: 328399)
1. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1977 Jul; 17(1):98-104. PubMed ID: 328399
[TBL] [Abstract][Full Text] [Related]
2. Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1979 Jun; 24(3):808-16. PubMed ID: 381202
[TBL] [Abstract][Full Text] [Related]
3. Protective ability of Salmonella ribosomal protein and RNA in inbred mice.
Misfeldt ML; Johnson W
Infect Immun; 1978 Jul; 21(1):286-91. PubMed ID: 30697
[TBL] [Abstract][Full Text] [Related]
4. Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1976 Sep; 14(3):652-9. PubMed ID: 786889
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
6. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
Nickol AD; Bonventre PF
J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
[TBL] [Abstract][Full Text] [Related]
7. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection.
Kita E; Oku D; Nishikawa F; Emoto M; Yasui K; Kashiba S
FEMS Microbiol Immunol; 1991 Aug; 3(4):229-39. PubMed ID: 1931135
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.
Hoops P; Prather NE; Berry J; Ravel JM
Infect Immun; 1976 Apr; 13(4):1184-92. PubMed ID: 776831
[TBL] [Abstract][Full Text] [Related]
9. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.
Eisenstein TK; Killar LM; Sultzer BM
J Infect Dis; 1984 Sep; 150(3):425-35. PubMed ID: 6207248
[TBL] [Abstract][Full Text] [Related]
10. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
Lin JH; Berry LJ
J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
[No Abstract] [Full Text] [Related]
11. Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.
Phillips M; Eisenstein TK; Meissler J
Infect Immun; 1985 Apr; 48(1):244-7. PubMed ID: 3980087
[TBL] [Abstract][Full Text] [Related]
12. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
Jirillo E; Kiyono H; Michalek SM; McGhee JR
J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
[TBL] [Abstract][Full Text] [Related]
13. Induction of immunoenhancing factors for murine splenocyte cultures by Salmonella typhimurium ribosome and ribonucleic acid extracts.
Butler RC; Friedman H; Specter SC; Eisenstein TK
Infect Immun; 1981 Jun; 32(3):1123-7. PubMed ID: 6166565
[TBL] [Abstract][Full Text] [Related]
14. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
Svenson SB; Nurminen M; Lindberg AA
Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.
Angerman CR; Eisenstein TK
Infect Immun; 1980 Feb; 27(2):435-43. PubMed ID: 6991415
[TBL] [Abstract][Full Text] [Related]
16. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.
Killar LM; Eisenstein TK
Infect Immun; 1985 Mar; 47(3):605-12. PubMed ID: 3882560
[TBL] [Abstract][Full Text] [Related]
17. Immunity to experimental Salmonella infection: studies on the protective capacity and immunogenicity of lipopolysaccharide, acetone-killed cells, and ribosome-rich extracts of Salmonella typhimurium in C3H/HeJ and CD-1 mice.
Eisenstein TK; Angerman CR
J Immunol; 1978 Sep; 121(3):1010-4. PubMed ID: 690428
[No Abstract] [Full Text] [Related]
18. Immunogenicity of the ribosomal fraction of Salmonella typhimurium: analysis of humoral immunity.
Kita E; Kashiba S
Infect Immun; 1980 Jan; 27(1):197-203. PubMed ID: 6987167
[TBL] [Abstract][Full Text] [Related]
19. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.
Eisenstein TK
Infect Immun; 1975 Aug; 12(2):364-77. PubMed ID: 51007
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression.
al-Ramadi BK; Greene JM; Meissler JJ; Eisenstein TK
Microb Pathog; 1992 Apr; 12(4):267-78. PubMed ID: 1630297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
